Outsourced Pharma Capacity Update Videos - Large Molecule
-
EirGenix Capacity Update May 2024: Large Molecule Development
6/12/2024
EirGenix has immediate capacity availability up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial. The microbial capacity will increase to 350L and 1,000L by 2025.
-
Singota Solutions Capacity Update May 2024: Large Molecule Development
6/11/2024
Review our Analytical, Product and Process Development, and Manufacturing capabilities along with the knowledge required to demonstrate product and process understanding.
-
AGC Biologics Capacity Update May 2024: Large Molecule Development
6/11/2024
Learn more about our global Biologics network, track record, and capabilities. Plus, take a detailed look at our Copenhagen site and how we balance flexibility with scale to meet the demands of clients.
-
Scorpius Biomanufacturing Capacity Update May 2024: Large Molecule Development
6/11/2024
Our facility offers ~2,000 sq. ft. of process and analytical development labs and ~8,600 sq. ft. of cGMP-compliant cleanroom manufacturing space for mammalian and microbial programs.
-
Mabion Capacity Update May 2024: Large Molecule Development
6/11/2024
Review our installations in upstream development, downstream development, and fill & finish. Our EU-GMP certified facility is staffed by a team of 250 professionals and focuses on providing CDMO services.